Skip to content

Welcome to Discover Pharma! Today is : November 8, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Clinical & Regulatory

  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    DEBRA Research and University Medical Center Groningen launch dedicated clinical trial site for Epidermolysis Bullosa

    DEBRA Research and the University Medical Center Groningen (UMCG) have [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    AAVantgarde completes enrollment in LUCE-1 Phase 1 and Phase 2 trial of gene therapy AAVB-081 for Usher syndrome type 1B

    AAVantgarde Bio has completed enrollment in LUCE-1, a first-in-human Phase [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Immunai partners with Bristol Myers Squibb to apply immune system AI in clinical development

    Artificial Intelligence, Biotech, Clinical Development, Clinical studies, Drug Development, Partnerships [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Cereno Scientific publishes first peer-reviewed data on HDAC inhibitor CS014 showing antithrombotic effects without bleeding risk

    Cereno Scientific has published the first peer-reviewed paper describing its [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Almirall to launch phase 3 LumiNE study of lebrikizumab in nummular eczema

    Almirall has announced plans to initiate a phase 3 clinical [...]

    May 5, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Alto Neuroscience secures new US method-of-treatment patent for ALTO-207 in depression

    Alto Neuroscience has strengthened its intellectual property position around its [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Therapeutic Areas

    Veristat names Kim McLean Boericke as CEO to drive next phase of clinical research growtheristat names Kim McLean Boericke as CEO to drive next phase of clinical research growth

    Veristat, a global clinical research organization (CRO) and consultancy specializing [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics

    iXCells names Steve Smith CEO to advance human iPSC preclinical services

    iXCells Biotechnologies has appointed Steve Smith as chief executive officer, [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data

    Qureight names Rebecca Simmons COO to lead operational scaling

    Qureight has appointed Rebecca Simmons as chief operating officer, strengthening [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory

    Novotech appoints Anand Tharmaratnam as CEO

    Novotech has appointed Anand Tharmaratnam as chief executive officer, following [...]

    May 5, 2026
Previous383940Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Hansa Biopharma treats first commercial kidney transplant patient with Idefirix in Australia
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • PhaseV survey finds 88% of sponsors face five-week delays in clinical trial reporting
    Categories: Clinical & Regulatory, Digital & Data, Drug Discovery & Development
  • NICE recommends glycopyrronium cream for severe underarm sweating
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top